Subretinal injection of human stem cell-derived retinal pigment epithelium yielded promising results in patients with geographic atrophy, according to preliminary data presented at the American Society of Retina Specialists annual meeting.
“[This is] some very exciting study data that potentially shows the promise of using stem cells to repair damage in the eyes from these diseases, which we’ve never been able to do before,” Vivienne S. Hau, MD, PhD, of Kaiser Permanente Bernard J. Tyson School of Medicine, told Healio.